Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: A randomized controlled trial

Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: A randomized controlled trial

Introduction. Procalcitonin (PCT) is a thyroid gland prohormone, and its serum concentration is elevated in systemic bacterial infections. The diagnostic cut-off value of PCT in patients early after cardiac surgery remains unclear. Objective. We investigated whether procalcitonin-guidance could...

Full description

Bibliographic Details
Main Authors:	Marinković Jelena, Borzanović Milorad, Ranković Aleksandra, Maravić-Stojković Vera, Laušević-Vuk Ljiljana, Jović Miomir
Format:	Article
Language:	English
Published:	Serbian Medical Society 2011-01-01
Series:	Srpski Arhiv za Celokupno Lekarstvo
Subjects:	procalcitonin antibiotics inflammatory mediators cardiac surgery
Online Access:	http://www.doiserbia.nb.rs/img/doi/0370-8179/2011/0370-81791112736M.pdf

Similar Items

Guiding Effect of Serum Procalcitonin (PCT) on the Antibiotic Application to Patients with Sepsis
by: Yu LIU, et al.
Published: (2017-11-01)

Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
by: Ashitha L. Vijayan, et al.
Published: (2017-08-01)

The role of the procalcitonin test in the diagnosis of infections in immune-mediated inflammatory rheumatic diseases
by: N. V. Muravyeva, et al.
Published: (2019-12-01)

PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial
by: Ajith K. Siriwardena, et al.
Published: (2019-07-01)

Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock
by: Andreas Hohn, et al.
Published: (2018-06-01)

The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke
by: Andreas Meisel, et al.
Published: (2017-04-01)

Procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia: a prospective observational study
by: Wang Q, et al.
Published: (2019-04-01)

Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections
by: Werner C. Albrich, et al.
Published: (2013-01-01)

The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit
by: Atabak Najafi, et al.
Published: (2015-10-01)

Elevated postoperative serum procalcitonin is not indicative of bacterial infection in cardiac surgical patients
by: Murali Chakravarthy, et al.
Published: (2015-01-01)

Diagnostic accuracy of clinical tool ‘STOPS’ and Serum Procalcitonin for optimizing antibiotic therapy in Neonatal Sepsis
by: Vishal Vishnu Tewari
Published: (2021-02-01)

Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD
by: Corti C, et al.
Published: (2016-06-01)

The Impact of Treatment on Serum Level of Procalcitonin in Patients with Active Pulmonary Tuberculosis
by: Hassan Ghobadi, et al.
Published: (2014-11-01)

The real life application of a procalcitonin-based algorithm to reduce antibiotic exposure in hospitalized patients with community acquired pneumonia: a proof of concept
by: Filippo Pieralli, et al.
Published: (2016-09-01)

Diagnostic and prognostic role of procalcitonin in CAP
by: Ayman S. El-dib, et al.
Published: (2015-10-01)

Misleading Serum Procalcitonin Elevation in Heatstroke
by: Marco Enzo Tau, et al.
Published: (2017-10-01)

Procalcitonin and its efficacy in reducing duration of antibiotics in critically ill patients with sepsis
by: Danek, Kelly Jean
Published: (2019)

Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit
by: Lesley Heesom, et al.
Published: (2020-09-01)

Effect of procalcitonin-guided therapy on antibiotic usage in the management of patients with chronic obstructive pulmonary disease with acute exacerbation
by: Randa S. Mohammad, et al.
Published: (2016-06-01)

Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials
by: Yannick Wirz, et al.
Published: (2018-08-01)

A meta-analysis to assess usefulness of procalcitonin-guided antibiotic usage for decision making
by: Nusrat Shafiq, et al.
Published: (2017-01-01)

Use of Procalcitonin during the First Wave of COVID-19 in the Acute NHS Hospitals: A Retrospective Observational Study
by: Neil Powell, et al.
Published: (2021-05-01)

Value of serum procalcitonin as an early predictor of antibiotic treatment response in inpatients with pelvic inflammatory disease (VALID)
by: In Kyung Hong, et al.
Published: (2020-09-01)

Procalcitonin as a marker of diabetic foot ulcer infection
by: Nabil A El-Kafrawy, et al.
Published: (2019-01-01)

Predictive efficacy of procalcitonin, platelets, and white blood cells for sepsis in pediatric patients undergoing cardiac surgeries who are admitted to intensive care units: Single-center experience
by: Jigar Surti, et al.
Published: (2018-01-01)

Elevated Procalcitonin as a Risk Factor for Postoperative Delirium in the Elderly after Cardiac Surgery—A Prospective Observational Study
by: Anna Kupiec, et al.
Published: (2020-11-01)

Endotoxins and the importance of procalcitonin
by: Paola Andrea Yasnó-Navia, et al.
Published: (2019-01-01)

Comparison of Procalcitonin Assays on KRYPTOR and LIAISON<sup>®</sup> XL Analyzers
by: Mariella Dipalo, et al.
Published: (2019-08-01)

The role of procalcitonin in reducing antibiotics across the surgical pathway
by: Massimo Sartelli, et al.
Published: (2021-03-01)

Procalcitonin to Reduce Antibiotic Exposure during Acute Chest Syndrome in Adult Patients with Sickle-Cell Disease
by: Keyvan Razazi, et al.
Published: (2020-11-01)

Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis
by: Hui-Bin Huang, et al.
Published: (2017-11-01)

C-reactive protein versus procalcitonin. Simillar but different biomarkers in the assessment of an infection
by: Mateusz Tyniec, et al.
Published: (2018-12-01)

Plasma levels of procalcitonin and eight additional inflammatory molecules in febrile neutropenic patients
by: Letícia Carvalho Neuenschwander, et al.
Published: (2011-01-01)

Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial
by: Jin-Xiang Wang, et al.
Published: (2016-07-01)

Prognostic Role of Serum Procalcitonin Measurement in Adult Patients Admitted to the Emergency Department with Fever
by: Marcello Covino, et al.
Published: (2021-06-01)

Procalcitonin: handle with care
by: Giuseppe Chesi, et al.
Published: (2016-09-01)

Evaluation of Plasmatic Procalcitonin in Healthy, and in Systemic Inflammatory Response Syndrome (SIRS) Negative or Positive Colic Horses
by: Irene Nocera, et al.
Published: (2021-07-01)

Procalcitonin in clinical practice: from diagnosis of sepsis to antibiotic therapy
by: Gabriele Cioni, et al.
Published: (2021-03-01)

Evaluation of Serum Procalcitonin in Patients with Systemic Inflammatory Response Syndrome with and without Infection
by: Jalili Mohammad, et al.
Published: (2009-10-01)

Evaluation of Serum Procalcitonin in Patients with Systemic Inflammatory Response Syndrome with and without Infection
by: Zahra Ahmadinejad, et al.
Published: (2009-10-01)